drug
pembrolizumab biosimilar
Phase 1updated 3mo agoby Formycon AG
Phase 1community read0 votes
indications
indications
Melanoma
all catalysts(0)
nothing on the calendar yet
Trials studying pembrolizumab biosimilar
- phase3A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
- phase3Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that